Jump to content

Anat Cohen-Dayag

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Ser Amantio di Nicolao (talk | contribs) at 05:26, 21 February 2023 (Copying from Category:21st-century Israeli businesswomen to Category:21st-century Israeli businesspeople using Cat-a-lot). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Anat Cohen-Dayag
Nationality Israel
Alma materWeizmann Institute of Science
Ben-Gurion University
Scientific career
Fieldsbiochemist

Anat Cohen-Dayag is an Israeli businesswoman. She is president and chief executive officer of the Israeli biotechnology firm Compugen Ltd, a company involved in drug discovery. She previously worked as a scientist at the R&D department of Orgenics.

Education

She holds a B.Sc. in Biology from the Ben-Gurion University, and has obtained an MSc in Chemical Immunology and a PhD in Biological Chemistry from the Weizmann Institute of Science.[1][2][3]

References

  1. ^ "Anat Cohen Dayag - Forbes". People.forbes.com. 2012-04-18. Archived from the original on 2011-06-11. Retrieved 2012-08-14.
  2. ^ "Compugen Appoints Dr. Anat Cohen-Dayag as President and CEO". FierceBiotech. Retrieved 2012-08-14.
  3. ^ "Compugen Appoints Dr. Anat Cohen-Dayag as President and CEO". www.fiercebiotech.com. Retrieved 2021-03-14.
Stub icon

This business-related Israeli biographical article is a stub. You can help Wikipedia by expanding it.

Flag of IsraelScientist icon Stub icon

This article about an Israeli scientist is a stub. You can help Wikipedia by expanding it.

Stub icon

This article about a biochemist is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Anat_Cohen-Dayag&oldid=1140672695"